Changchun BCHT Biotechnology Co. (688276.SS) SHH
17.87
+0.14(+0.79%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
17.87
+0.14(+0.79%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1241
First IPO Date
June 25, 2021
| Name | Title | Pay | Year Born |
| Chunlai Jiang | GM & Director | 0 | 1973 |
| Dawei Liu | Deputy General Manager | 0 | 1972 |
| Wei Wei | Deputy General Manager | 0 | 1970 |
| Xiaohui Chen | Chief Operating Specialist | 0 | N/A |
| Zhaofeng Meng | Chief Financial Officer | 0 | 1964 |
| Zhe Zhang | Board Secretary | 0 | 1976 |
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. Its products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. The company was founded in 2004 and is based in Changchun, China.